Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Biogen Inc Recent news which mentions Biogen Inc < Previous 1 2 3 Next > 5 things to know before the stock market opens Monday September 09, 2024 Tags Rivian Automotive Inc Norfolk Southern Corp Investment strategy From CNBC.com News Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment September 08, 2024 Tags Business News Health & Science Breaking News: Business From CNBC.com News Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction August 01, 2024 Tags Business Pharmaceuticals Breaking news From CNBC.com News Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says July 30, 2024 Tags Health care industry Eisai Co Ltd Biotech and Pharmaceuticals From CNBC.com News Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says July 30, 2024 Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry From CNBC.com News European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai July 26, 2024 Tags Health & Science Business News US: News From CNBC.com News Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug June 11, 2024 Tags Stock markets stocks Business From CNBC.com News Cramer's Lightning Round: Bank of America is a buy May 10, 2024 Tags Fidelis Insurance Holdings Ltd Chevron Corp Investing From CNBC.com News Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up April 24, 2024 Tags Breaking news Pharmaceuticals Business From CNBC.com News 5 things to know before the stock market opens Monday April 22, 2024 Tags Southwest Airlines Co Chipotle Mexican Grill Inc Chevron Corp From CNBC.com News Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move March 08, 2024 Tags Pharmaceuticals Business Biotechnology From CNBC.com News Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start February 20, 2024 Tags Biotech and Pharmaceuticals Health & Science Biogen Inc From CNBC.com News Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies February 13, 2024 Tags Biotech and Pharmaceuticals Earnings Eisai Co Ltd From CNBC.com News 5 things to know before the stock market opens Monday February 12, 2024 Tags Restaurant Brands International Inc Coinbase Global Inc Verizon Communications Inc From CNBC.com News Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments January 31, 2024 Tags Science Pharmaceuticals Business From CNBC.com News Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma December 20, 2023 Tags Business News Health & Science Biotechnology From CNBC.com News 5 things to know before the stock market opens Monday November 06, 2023 Tags MGM Resorts International Business Walt Disney Co From CNBC.com News More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study October 25, 2023 Tags Biotech and Pharmaceuticals Health care industry Eisai Co Ltd From CNBC.com News Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug August 07, 2023 Tags Biotech and Pharmaceuticals Depression Health care industry From CNBC.com News Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more July 28, 2023 Tags Market Insider Pfizer Inc Markets From CNBC.com News Stocks making the biggest moves midday: Spotify, RTX, General Electric and more July 25, 2023 Tags 3M Co Biogen Inc Spotify Technology SA From CNBC.com News Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch July 25, 2023 Tags Business Pharmaceuticals Wells Fargo & Co From CNBC.com News 5 things to know before the stock market opens Tuesday July 18, 2023 Tags Investment strategy Citigroup Inc Politics From CNBC.com News Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year July 17, 2023 Tags Biotech and Pharmaceuticals Health care industry Eli Lilly and Co From CNBC.com News Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know July 08, 2023 Tags Politics Biotech and Pharmaceuticals Policy From CNBC.com News Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024 July 07, 2023 Tags Science Business Pharmaceuticals From CNBC.com News Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more July 07, 2023 Tags Breaking News: Markets Stock markets Levi Strauss & Co From CNBC.com News Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more July 07, 2023 Tags Tesla Inc Biogen Inc Economy From CNBC.com News Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug July 07, 2023 Tags World Markets Science Asia Markets From CNBC.com News FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage July 06, 2023 Tags Health & Science Breaking News: Business Business News From CNBC.com News < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.